TipRanks
Go Ultimate55% OFF

Oruka Therapeutics (HQ1) Income Statement

Oruka Therapeutics Income Statement

Last quarter (Q2 2026), Oruka Therapeutics's total revenue was $0.00. In Q2, Oruka Therapeutics's net income was $-41.21M. See Oruka Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 22Dec 21Dec 20
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -83.00K$ -27.00K$ -114.00K$ -91.00K$ -93.00K
$ 121.97M$ 88.10M$ 9.73M$ 19.24M$ 9.67M
Depreciation and Amortization$ 83.00K$ 27.00K$ 114.00K$ 91.00K$ 93.00K
$ -105.35M$ -82.23M$ -9.81M$ -19.23M$ -9.64M
$ -122.05M$ -88.12M$ -9.84M$ -19.34M$ -9.77M
$ 16.62M$ 4.40M$ -85.00K$ 13.00K$ 19.00K
$ -105.43M$ -83.72M$ -9.93M$ -19.32M$ -9.75M
$ -105.43M$ -83.72M$ -9.93M$ -19.32M$ -9.74M
Per Share Metrics
Basic EPS$ -2.31$ -4.99$ -8.27$ -16.68$ -8.40
Diluted EPS$ -2.31$ -4.99$ -8.27$ -16.68$ -8.40
Weighted Average Shares Outstanding45.61M16.79M14.41M13.90M4.71M
Weighted Average Shares Outstanding (Diluted)45.61M16.79M14.41M13.90M4.71M

Currency in USD

Oruka Therapeutics Earnings and Revenue History

-120M-80M-40M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20172018201920202021202220242025RevenueEarningsProfit Margin